Siemens Healthineers Launch Enhanced Liver Fibrosis Test in US
The ELF Test is a blood test that assesses prognosis in patients with advanced fibrosis due to non-alcoholic steatohepatitis (NASH).
Read MorePosted by Andy Lundin | Jan 27, 2022 | Diabetes & Metabolic Diseases, Diagnostic Technologies |
The ELF Test is a blood test that assesses prognosis in patients with advanced fibrosis due to non-alcoholic steatohepatitis (NASH).
Read MorePosted by Andy Lundin | Jan 24, 2022 | Anatomic Pathology, Rapid Assays |
The FDA has granted Pathogenomix with a Breakthrough Device Designation for its Patho-Seq assay due to its methodologies of pathogenic bacteria diagnosis.
Read MorePosted by Chris Wolski | Jan 17, 2022 | Specimen Collection & Handling |
Akoya Biosciences has announced the commercial availability of the PhenoCycler-Fusion system for high-speed imaging of whole slides.
Read MorePosted by Andy Lundin | Jan 14, 2022 | Covid 19, Dementias & Alzheimer’s |
The new study found higher levels of seven markers of brain damage in COVID-19 patients with neurological symptoms than those without them.
Read MorePosted by Andy Lundin | Jan 13, 2022 | Immunoassay Reagents & test Kits |
During a month-long mission, around 4,000,000 testing kits will be delivered to the respective state authorities for distribution.
Read More